Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors best predict relapse in patients with the kidney disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-we-predict-relapse-drug-response-anca-associated-2026a10006tr?src=rss
Author :
Publish date : 2026-03-05 11:56:00
Copyright for syndicated content belongs to the linked Source.
